Skip to main content
. 2020 Jul;21(7):537–548. doi: 10.1631/jzus.B2000049

Table 4.

Comparison of the characteristics of survivals and non-survivals

 Characteristics 28-d survivals (n=79) 28-d non-survivals (n=68) P
 Age (year) 63.9±15.8 68.5±14.7 0.086
 Sex, male 66 (83.5%) 54 (79.4%) 0.666
 Treatment day in ICU 18.4±8.2 25.7±8.5 0.000
 Stroke 41 (51.9%) 34 (50.0%) 0.392
 Trauma 47 (59.5%) 39 (57.4%) 0.925
 Shock 16 (20.3%) 34 (50.0%) 0.000
 COPD 40 (50.6%) 32 (47.1%) 0.790
 cTnI (μg/L) 0.93 (0.14/1.25) 0.91 (0.12/1.76) 0.063
 BNP (pg/mL) 626.0 (346.5/870.0) 707.5 (409.5/1305.5) 0.018
 h-FABP (ng/mL) 8.44 (4.96/10.99) 10.16 (8.40/12.20) 0.030
 PAPP-A (ng/mL) 3.57 (1.99/6.36) 4.72 (2.92/7.42) 0.002
 MPO (ng/mL) 12.62 (8.37/17.80) 15.65 (10.59/26.15) <0.0005
 PCT (μg/L) 3.50 (1.89/5.65) 3.30 (1.99/5.30) 0.838
 APACHE-II score (points) 19.1±3.0 19.2±3.0 0.791
 SOFA score (points) 10.4±2.4 10.2±2.2 0.470
 MODS score (points) 11.1±2.3 11.8±2.3 0.109

Data are expressed as mean±standard deviation (SD), number (percentage), or median (25th/75th percentile). ICU: intensive care unit; COPD: chronic obstructive pulmonary disease; cTnI: cardiac troponin I; BNP: brain natriuretic peptide; h-FABP: heart-type fatty acid-binding protein; PAPP-A: pregnancy-associated plasma protein-A; MPO: myeloperoxidase; PCT: procalcitonin; APACHE-II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; MODS: Multiple Organ Dysfunction Syndrome